NCT05421442View on ClinicalTrials.gov

A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

Active, not recruitingOBSERVATIONAL
Enrollment

1,450

Participants

Timeline

Start Date

June 13, 2019

Primary Completion Date

September 4, 2025

Study Completion Date

January 30, 2026

Conditions
Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)
Trial Locations (1)

08543

Local Institution - 0001, Lawrenceville

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05421442 - A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database | Biotech Hunter | Biotech Hunter